Invited Speakers
Confirmed International Speakers
- David H. Kirn, MD, President and CEO of JENNEREX Biotherapeutics, San Francisco, USA
"Oncolytic poxviruses for cancer therapy"
http://www.jennerex.com/pr-060208.html
- Shahriar S. Yaghoubi, Ph.D., Molecular Imaging Program, Department of Radiology, School of Medicine, Stanford University, USA
"Application of molecular imaging in gene and cell therapy"
http://mips.stanford.edu/public/faculty-info?personnel_id=124
- Ryszard Kole, Ph.D., Senior Vice President of Discovery Research, AVI BioPharma Inc, USA
"Antisense treatment for thalassemia"
http://www.avibio.com/company_overview.php
- Jeff Chamberlain, PhD, Professor, Depts. of Neurology, Medicine and Biochemistry, University of Washington School of Medicine, Seattle, USA.
"Gene therapy for muscular disorders"
http://depts.washington.edu/biowww/faculty/chamberlain.html
- Anthony Gringeri, PhD, Chief Operating Officer, AMT Biopharma, Amsterdam, Netherlands.
"Lipoprotein Lipase gene therapy using AAV vectors"
http://www.amtbiopharma.com/team.php?menu=102
National Speakers
|
